PharmTech Talk

Dec 03, 2018
The proposal from the Centers for Medicare and Medicaid Services (CMS) proposes to give plans more flexibility to limit coverage of certain drugs.
Nov 29, 2018
Despite ongoing efforts to address the problem, FDA now sees a rise in active shortages and in the duration of supply problems.
Nov 16, 2018
Moving forward with gene therapy development requires a “quantum leap” in manufacturing capabilities.
Nov 08, 2018
Leaders of the two parties are open to challenging the status quo on drug costs and spending.
Oct 26, 2018
A new proposal aims to reduce reimbursement for medicines administered to seniors under the Part B benefit to an amount pegged to the average price paid in foreign industrial nations.
Oct 19, 2018
Pharmaceutical Technology
To achieve a more dynamic marketplace, FDA is issuing guidance documents and targeted advisories to support R&D on complex generics and combination products.
Oct 18, 2018
The US Department of Health and Human Services has published its proposed rule on the disclosure of drug prices, just in time for the November mid-term elections.
Oct 10, 2018
Congress approves bills with provisions important to FDA and industry, some of which reflect continuing concerns about drug pricing and transparency.
Oct 01, 2018
FDA is joining with other federal health agencies and the biomedical research community to advance the science, regulatory policies, and reimbursement strategies to support innovation in antimicrobials.
Sep 27, 2018
CDER director plans to start implementation of new review practices by the end of 2018.
lorem ipsum